Andrei Shustov
Chief Tech/Sci/R&D Officer at CELLECTAR BIOSCIENCES, INC.
Net worth: 166 212 $ as of 30/04/2024
Andrei Shustov active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 15/02/2023 | - |
Career history of Andrei Shustov
Former positions of Andrei Shustov
| Companies | Position | Start | End |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - | - |
Training of Andrei Shustov
| S. I. Georgievsky's Medical Academy | Doctorate Degree |
Statistics
International
| United States | 3 |
| Russia | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CELLECTAR BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Andrei Shustov
- Experience
